The Hydrocephalus Shunts Market involves the production and sales of devices used to treat hydrocephalus, a condition characterized by the accumulation of excess cerebrospinal fluid within the brain. Hydrocephalus shunts are devices that are surgically implanted to drain the excess fluid to another part of the body, typically the peritoneal cavity.
The hydrocephalus shunts market is driven by the increasing incidence of hydrocephalus and advancements in medical technology. Key players in the market include Medtronic, DePuy Synthes, Natus Medical, and Integra LifeSciences. The market is expected to grow at a steady pace, with an estimated CAGR of 4-5% from 2021 to 2026.
The market is segmented based on product type (ventriculoperitoneal shunt, lumboperitoneal shunt, and others), end-user (hospitals, ambulatory surgical centers, and others), and geography. The market is highly competitive, with significant investment in research and development, and product launches by leading companies.
Drivers, restraints, and opportunities-
Rise in prevalence of hydrocephalus, growth in adoption of advanced programmable valves, and surge in incidences of neurological disorder drive the growth of the global hydrocephalus shunts market. However, shunt malfunction and related infections and shunt-free treatments for hydrocephalus restrain the market growth. On the other hand, advancements in smart shunt technology is anticipated to present new opportunities in the coming years.
Request Sample Report at:Β https://www.alliedmarketresearch.com/request-sample/2682
Covid-19 Scenario-
The covid-19 outbreak has led to inconsistent and interrupted supply chain activities and lack of human resources. This has created numerous challenges for the industry.
The lockdowns imposed to curb the spread had resulted in shutdown of neurological wards and clinics across several countries.
Owing to the growing number of corona patients, most of the neurosurgeons were reassigned to COVID-19 wards, which deteriorated inconsistencies in access for neurosurgical treatments for hydrocephalic patients.
The ventriculo-peritoneal shunts segment to maintain its dominant share during the forecast period-
Based on type, the ventriculo-peritoneal shunts segment held the highest market share in 2019, accounting for more than two-fifths of the total share of the global hydrocephalus shunts market, and is expected to maintain its dominant share during the forecast period. This is attributed to the development in neurosurgical techniques along with advances in the shunt technology. However, the ventriculo-pleural shuntssegment is expected to witness the highest CAGR of 3.3% from 2020 to 2027. The fact that VA shunts are promising alternatives for patients who are intolerant to VP shunts drives the growth of the segment.
The children segment to maintain its lead status by 2027-
Based on age-group, the children segment contributed to the highest market share in 2019, accounting for nearly half of the total share of the global hydrocephalus shunts market, and is projected to maintain its leadership status by 2027. This is due to increase in incidences of acquired and compensated hydrocephalus in children. However, the adults segment is expected to grow at the highest CAGR of 3.0% during the forecast period, owing to increase in prevalence of normal pressure hydrocephalus (NPH) that remains undetected for several years and is caused from various lifestyle changes and disorders.
Procure Complete Report (220 Pages PDF with Insights, Charts, Tables, and Figures) @Β https://www.alliedmarketresearch.com/checkout-final/38536a8d74fcf3ddc2f45a9c0350c9d1
North America region to dominate the market throughout 2027-
The global hydrocephalus shunts market across North America, contributed to the highest share in terms of revenue, holding more than two-fifths of the total market share in 2019. This is owing to the presence of key medical devices companies in the region. However, the Asia-Pacific region is estimated to manifest the fastest CAGR of 3.3% from 2020 to 2027, owing to increase in awareness regarding neurological diseases and related treatment options in the region, along with a rising incidences of strokes.
Inquiry for Buying@Β https://www.alliedmarketresearch.com/purchase-enquiry/2682
Leading market players-
Christoph Miethke GmbH & Co. KGG.
Surgiwear Ltd.
HLL Lifecare Limited
HpBio PrΓ³teses, Inc.
Integra Life Sciences
Kaneka Medix Corporation
Medtronic plc
Natus Medical Incorporated
Spiegelberg GmbH & CO. KG
Tokibo Co., Ltd.
Key Findings Of The Study
By type, the ventriculo-pleural shunts segment is projected to grow at the highest rate during the analysis period.
By age group, the children segment is expected to dominate the global hydrocephalus shunts market throughout the forecast period.
By region, North America was the largest market in 2019, and is projected to maintain its lead during the forecast period.
πππ‘ππ« ππ«ππ§ππ’π§π πππ©π¨π«ππ¬:
Acupuncture Needles Market: https://www.alliedmarketresearch.com/acupuncture-needles-market
Cystic Fibrosis (CF) Therapeutics Market: https://www.alliedmarketresearch.com/cystic-fibrosis-therapeutics-market
ππ¨π§ππππ:
David Correa
5933 NE Win Sivers Drive#205,
Portland, OR 97220
United States
USA/Canada (Toll Free) : +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.